NEXENTIS TECHNOLOGIES INC. Cash Provided by (Used in) Operating Activities, Discontinued Operations
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Cash Provided by (Used in) Operating Activities, Discontinued Operations of -$27.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations · last filed 2026-08-13
- NEXENTIS TECHNOLOGIES INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2026-06-30 was $0.00.
- NEXENTIS TECHNOLOGIES INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2026-03-31 was -$27.00K.
- NEXENTIS TECHNOLOGIES INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2025-06-30 was -$113.00K.
- NEXENTIS TECHNOLOGIES INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2025-03-31 was -$127.00K.
- NEXENTIS TECHNOLOGIES INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2025 was -$600.00K.
- NEXENTIS TECHNOLOGIES INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2024 was -$746.00K.
| Period end | Cash Provided by (Used in) Operating Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 6 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 9 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$27.00K 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | -$27.00K 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | -$600.00K 10-K · filed 2026-03-31 | |||
| 2025-06-30 | -$113.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$240.00K 10-Q · filed 2026-08-13 | -$734.00K derived: sum of 3 quarters · filed 2026-08-13 | |
| 2025-03-31 | -$127.00K 10-Q · filed 2026-05-14 | -$621.00K derived: sum of 2 quarters · filed 2026-05-14 | ||
| 2024-12-31 | -$494.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$746.00K 10-K · filed 2026-03-31 | ||
| 2024-09-30 | -$252.00K 10-Q · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |